Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Sterling

Showing results (51-60 of 61) with videos related to

Pageof 7
Sort By:
Transplantation and Cellular Therapy|July 22, 2021
Allogeneic Blood or Marrow Transplantation with Nonmyeloablative Conditioning and High-Dose Cyclophosphamide-Based Graft-versus-Host Disease Prophylaxis for Secondary Central Nervous System LymphomaCole H Sterling, Hua-Ling Tsai, Matthias Holdhoff, et al.
JACC. Advances|July 25, 2024
Resource Utilization and Costs Associated With Cardiogenic Shock Complicating Myocardial Infarction: A Population-Based Cohort StudySimon Parlow, Shannon M Fernando, Michael Pugliese, et al.
Transplantation and Cellular Therapy|December 22, 2022
Allogeneic Blood or Marrow Transplantation with Post-Transplantation Cyclophosphamide for Peripheral T Cell Lymphoma: The Importance of Graft SourceCole H Sterling, Michael S Hughes, Hua-Ling Tsai, et al.
Journal of the Society for Cardiovascular Angiography & Interventions|March 20, 2025
Point-of-Care Ultrasound for the Detection of Vascular Access Site Complications-The ULTRASITCOM StudyPietro Di Santo, Omar Abdel-Razek, Graeme Prosperi-Porta, et al.
Intensive Care Medicine|May 2, 2024
Mental health sequelae in survivors of cardiogenic shock complicating myocardial infarction. A population-based cohort studyShannon M Fernando, Danial Qureshi, Robert Talarico, et al.
Leukemia & Lymphoma|August 2, 2022
Mismatched donor transplantation with post-transplantation cyclophosphamide for advanced cutaneous T-cell lymphoma: a single-center retrospective studyMichael S Hughes, Cole H Sterling, Ravi Varadhan, et al.
Critical Care Medicine|January 8, 2026
Prognostic Factors Among Patients Receiving Microaxial Flow Pump for Acute Myocardial Infarction-Related Cardiogenic Shock: A Systematic Review and Meta-AnalysisSimon Parlow, Richard G Jung, Sayed Abdulmotaleb Almoosawy, et al.
American Heart Journal|April 24, 2023
Inotrope versus placebo therapy in cardiogenic shock: Rationale and study design of the CAPITAL DOREMI2 trialSimon Parlow, Pietro Di Santo, Lee H Sterling, et al.
Nature Cancer|December 22, 2025
TRBC2-targeting antibody-drug conjugates for the treatment of T cell cancersJiaxin Ge, Joshua Urban, Sarah R DiNapoli, et al.
Medrxiv : the Preprint Server for Health Sciences|December 16, 2024
Detection of human brain cancers using genomic and immune cell characterization of cerebrospinal fluid through CSF-BAMAlexander H Pearlman, Yuxuan Wang, Anita Kalluri, et al.
Pageof 7

Showing results (51-60 of 61) with videos related to

Sort By:
Pageof 7
Transplantation and Cellular Therapy|July 22, 2021
Allogeneic Blood or Marrow Transplantation with Nonmyeloablative Conditioning and High-Dose Cyclophosphamide-Based Graft-versus-Host Disease Prophylaxis for Secondary Central Nervous System LymphomaCole H Sterling, Hua-Ling Tsai, Matthias Holdhoff, et al.
JACC. Advances|July 25, 2024
Resource Utilization and Costs Associated With Cardiogenic Shock Complicating Myocardial Infarction: A Population-Based Cohort StudySimon Parlow, Shannon M Fernando, Michael Pugliese, et al.
Transplantation and Cellular Therapy|December 22, 2022
Allogeneic Blood or Marrow Transplantation with Post-Transplantation Cyclophosphamide for Peripheral T Cell Lymphoma: The Importance of Graft SourceCole H Sterling, Michael S Hughes, Hua-Ling Tsai, et al.
Journal of the Society for Cardiovascular Angiography & Interventions|March 20, 2025
Point-of-Care Ultrasound for the Detection of Vascular Access Site Complications-The ULTRASITCOM StudyPietro Di Santo, Omar Abdel-Razek, Graeme Prosperi-Porta, et al.
Intensive Care Medicine|May 2, 2024
Mental health sequelae in survivors of cardiogenic shock complicating myocardial infarction. A population-based cohort studyShannon M Fernando, Danial Qureshi, Robert Talarico, et al.
Leukemia & Lymphoma|August 2, 2022
Mismatched donor transplantation with post-transplantation cyclophosphamide for advanced cutaneous T-cell lymphoma: a single-center retrospective studyMichael S Hughes, Cole H Sterling, Ravi Varadhan, et al.
Critical Care Medicine|January 8, 2026
Prognostic Factors Among Patients Receiving Microaxial Flow Pump for Acute Myocardial Infarction-Related Cardiogenic Shock: A Systematic Review and Meta-AnalysisSimon Parlow, Richard G Jung, Sayed Abdulmotaleb Almoosawy, et al.
American Heart Journal|April 24, 2023
Inotrope versus placebo therapy in cardiogenic shock: Rationale and study design of the CAPITAL DOREMI2 trialSimon Parlow, Pietro Di Santo, Lee H Sterling, et al.
Nature Cancer|December 22, 2025
TRBC2-targeting antibody-drug conjugates for the treatment of T cell cancersJiaxin Ge, Joshua Urban, Sarah R DiNapoli, et al.
Medrxiv : the Preprint Server for Health Sciences|December 16, 2024
Detection of human brain cancers using genomic and immune cell characterization of cerebrospinal fluid through CSF-BAMAlexander H Pearlman, Yuxuan Wang, Anita Kalluri, et al.
Pageof 7